Anja heads our Life Sciences & Healthcare group in Germany. She is a specialist lawyer for intellectual property law, admitted as representative before the Unified Patent Court (UPC) and has specialized in patent law for 20 years. Anja manages and coordinates complex, multinational patent infringement proceedings and drafts infringement and nullity opinions. Further, she negotiates license as well as research and development negotiations.

 

She advises on parallel opposition and nullity proceedings before the European Patent Office, the Federal Patent Court and the Federal Supreme Court. In particular, Anja represents clients from the fields of pharmaceuticals, biotech, personalised medicine and precision medicine as well as from the chemical and medical device industries and advises on related issues of digitisation. Having spent time in Geneva, Strasbourg, Tokyo and London, Anja has intercultural competence and language skills (including English, French and Japanese).

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

Early IP Strategy for Life Sciences Start-Ups Pays off

We explain the 5 biggest pitfalls

22 mars 2024
Briefing

par Dr. Anja Lunze, LL.M. et Tobias Baus, LL.M., Dipl.-Ing.

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2

23 février 2024
In-depth analysis

par Dr. Anja Lunze, LL.M. et Tobias Baus, LL.M., Dipl.-Ing.

Cliquer ici pour en savoir plus
UPC

Forum Shopping at the UPC

Different routes for infringement and revocation proceedings?

6 février 2024
In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus
Brevets et innovation

11. January 2024 – CJEU Case C 473/22: Mylan AB v Gilead and others

12 janvier 2024
Quick read

par Dr. Anja Lunze, LL.M. et Dr. Aurel-Damian Roscher, LL.M.

Cliquer ici pour en savoir plus